Based in Israel, Biobeat is a startup. Brouky records 1 investor associated with the company.
Biobeat develops FDA-cleared, cuffless, wireless, and non-invasive medical-grade chest patch devices for 24-hour ambulatory blood pressure monitoring to improve hypertension diagnosis and management.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.